Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.

[1]  F. Coakley.  Staging ovarian cancer: role of imaging. , 2002, Radiologic clinics of North America.

[2]  H. Hricak,et al.  Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. , 2002, Radiology.

[3]  P. W. Jones,et al.  Can pre‐operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy? , 2002, BJOG : an international journal of obstetrics and gynaecology.

[4]  E. Fishman,et al.  A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography , 2000, Cancer.

[5]  E. Venkatraman,et al.  The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. , 2000, Gynecologic oncology.

[6]  B. McNeil,et al.  Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group. , 1999, Radiology.

[7]  Mcguire Wp,et al.  Chemotherapy of advanced ovarian cancer. , 1998 .

[8]  D. Chi,et al.  The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery. , 1998, Seminars in oncology.

[9]  E. Trimble,et al.  Patterns of care for women with ovarian cancer in the United States. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  K. Hatch,et al.  Neoadjuvant chemotherapy for advanced ovarian cancer , 1996, International Journal of Gynecologic Cancer.

[11]  H. Hricak,et al.  Ovarian cancer: staging with CT and MR imaging. , 1995, Radiology.

[12]  R. Zepp,et al.  Ovarian carcinoma: value of CT in predicting success of debulking surgery. , 1995, AJR. American journal of roentgenology.

[13]  H. Hricak,et al.  Imaging of ovarian cancer , 1995, Journal of magnetic resonance imaging : JMRI.

[14]  R. Yancik,et al.  Cancer in older persons. Magnitude of the problem‐how do we apply what we know? , 1994, Cancer.

[15]  J. Berek,et al.  The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. , 1994, American journal of obstetrics and gynecology.

[16]  R. Makuch,et al.  Neoadjuvant chemotherapy for advanced ovarian cancer , 1994, Gynecologic oncology.

[17]  B. Sevin,et al.  National survey of ovarian carcinoma part V. The impact of physician's specialty on patients' survival , 1993, Cancer.

[18]  K. Swenerton,et al.  Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  E. Yordan,et al.  Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Berek,et al.  Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  F. Naftolin,et al.  Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial , 1989, Cancer.

[22]  T. Fleming,et al.  Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. , 1985, Cancer treatment reports.

[23]  Griffiths Ct.  Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .

[24]  P. Schwartz.  Cytoreductive surgery for the management of stage IV ovarian cancer. , 1997, Gynecologic oncology.

[25]  P. Schwartz,et al.  Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.